13F-HR filed by Quadrature Capital Ltd
Quadrature Capital Ltd filed this 13F-HR for the quarter ended 2025-03-31, filed 2025-05-13, with 1,032 holding rows worth $4,509,523,701.
- Accession
- 0001651424-25-000006
- Filer
- CIK 1651424
- Filed
- 2025-05-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2025
A holdings report, 1,032 entries on the cover page, a total value of $4,509,523,701 stated on the cover page (in dollars after the unit check, H1), rows summing to $4,509,523,701 with VALUE read as dollars as filed, 13F file number 028-17020. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerQuadrature US Inc.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| INOZYME PHARMA INC | 45790W108 | COM | 39,496 | $35,546 | dollars as filed | |
| PROQR THERAPEUTICS NV | N71542109 | SHS EURO | 26,403 | $35,380 | dollars as filed | |
| BORR DRILLING LTD | G1466R173 | COMMON STOCK | 15,922 | $34,949 | dollars as filed | |
| ANNEXON INC | 03589W102 | COM | 17,732 | $34,489 | dollars as filed | |
| BIOMEA FUSION INC | 09077A106 | CMN | 16,077 | $34,244 | dollars as filed | |
| EXPENSIFY INC | 30219Q106 | COM CL A | 11,052 | $33,543 | dollars as filed | |
| CUREVAC N V | N2451R105 | COM | 11,872 | $33,123 | dollars as filed | |
| STANDARD BIOTOOLS INC | 34385P108 | COM | 30,310 | $32,886 | dollars as filed | |
| PERSPECTIVE THERAPEUTICS INC | 46489V302 | COMMON STOCK | 15,158 | $32,438 | dollars as filed | |
| ABCELLERA BIOLOGICS INC COM | 00288U106 | Stock | 14,584 | $32,376 | dollars as filed | |
| SERVICE PPTYS TR | 81761L102 | COM SH BEN INT | 12,323 | $32,225 | dollars as filed | |
| NIOCORP DEVS LTD | 654484609 | COM NEW | 16,166 | $32,009 | dollars as filed | |
| EVENTBRITE INC | 29975E109 | COM CL A | 14,751 | $31,051 | dollars as filed | |
| WHEELS UP EXPERIENCE INC | 96328L205 | COM CL A | 30,355 | $30,507 | dollars as filed | |
| CARECLOUD INC | 14167R100 | COM | 21,731 | $29,989 | dollars as filed | |
| FOSSIL GROUP INC | 34988V106 | COMMON STOCK | 25,602 | $29,570 | dollars as filed | |
| CERUS CORP | 157085101 | COM | 20,200 | $27,977 | dollars as filed | |
| ERASCA INC COM | 29479A108 | Stock | 20,366 | $27,901 | dollars as filed | |
| BRANCHOUT FOOD INC | 105230106 | COM | 10,803 | $26,413 | dollars as filed | |
| KYVERNA THERAPEUTICS INC | 501976104 | COMMON STOCK | 13,552 | $26,223 | dollars as filed | |
| C4 THERAPEUTICS INC | 12529R107 | COM STK | 16,009 | $25,534 | dollars as filed | |
| ACELYRIN INC | 00445A100 | COM | 10,246 | $25,256 | dollars as filed | |
| ALTO NEUROSCIENCE INC COM SHS | 02157Q109 | Stock | 11,402 | $24,685 | dollars as filed | |
| Ventyx Biosciences Inc | 92332V107 | Common Stock | 21,148 | $24,532 | dollars as filed | |
| COMMERCIAL VEH GROUP INC | 202608105 | COM | 21,061 | $24,431 | dollars as filed | |
| SELLAS LIFE SCIENCES GROUP I | 81642T209 | COM NEW | 20,673 | $22,223 | dollars as filed | |
| LARIMAR THERAPEUTICS INC | 517125100 | COM | 10,242 | $21,867 | dollars as filed | |
| METAGENOMI THERAPEUTICS INC | 59102M104 | COM | 14,198 | $19,451 | dollars as filed | |
| BTCS INC | 05581M404 | CMN | 11,655 | $17,483 | dollars as filed | |
| ALECTOR INC | 014442107 | COMMON STOCK | 12,949 | $15,992 | dollars as filed | |
| Inflarx Nv | N44821101 | COM | 13,858 | $14,412 | dollars as filed | |
| STANDARD LITHIUM CORP COM | 853606101 | Stock | 10,442 | $13,366 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001651424-25-000006 | this filing | 2025-05-13 | acceptance time not in the bulk data set |